Русский

Pharmaceutical Industry Information Portal

HomeTagsCDMO

All posts by tag

CDMO

Expert Articles

Contract production of pharmaceutical ingredients by 2028 may reach $ 136 billion

Techno -
The traditional active pharmaceutical ingredient dominated the market and accounted for the largest revenue share of 40.5% in 2020.
World Pharma News

AGC Biologics Eyeing to Significantly Expand Their Cell and Gene Therapy Capabilities

Techno -
AGC Biologics announced the signing of a purchase agreement for a state-of-the-art Cell and Gene Therapy commercial manufacturing facility in Longmont, currently owned by Novartis Gene Therapies.
Discovery and Development

Vectura to provide preclinical support for Incannex’s inhaled brain injury treatment

Techno -
IHL-216A may make sports safer and reduce the morbidity and mortality rates of people suffering serious head traumas.
World Pharma News

Yposkesi launches construction of its second commercial bioproduction site

Techno -
Yposkesi, a leading Contract Development and Manufacturing Organization (CDMO) specializing in cell and gene therapies, announces the launch of project SKY, the construction of...
spot_img

Expert Articles

spot_img

Information Internet project PharmProm.Net dedicated to the pharmaceutical industry in the world. It contains a contact base of organizations, enterprises, companies associated with the pharmaceutical market. The editorial staff of the PharmProm.Net portal offers cooperation in the field of information promotion and advertising in the pharmaceutical market.

Read our Russian-language online magazine

Categories